Clinical Trials Search at Vanderbilt-Ingram Cancer Center
Nivolumab and Ipilimumab in Estimating Anti-Tumor Activity and Identifying Potential Predictors of Response in Patients with Melanoma That is Metastatic or Cannot Be Removed by Surgery
Melanoma
Melanoma
This phase II trial studies how well nivolumab and ipilimumab work in estimating anti-tumor activity and identifying potential predictors of response in patients with melanoma that is spreading to other places in the body or that cannot be removed by surgery. Monoclonal antibodies, such as nivolumab and ipilimumab, may interfere with the ability of tumor cells to grow and spread.
Melanoma
N/A
Johnson, Douglas
NCT02978443
VICCMEL1816
A Registry Study to Evaluate the Survival and Long-Term Safety of Subjects Who Previously Received Talimogene Laherparepvec in Amgen or BioVEX-Sponsored Clinical Trials
Melanoma
Melanoma
Melanoma
N/A
Johnson, Douglas
NCT02173171
VICCMEL14103
Investigating Immune Responses in Patients with Advanced Melanoma Treated with Immune-Based Therapy
Melanoma
Melanoma
Melanoma
N/A
Irish, Jonathan
VICCMEL15148
Melanoma, Pigmented Lesion and Cutaneous Malignancy Tissue and Bio-Specimen Repository
Multiple Cancer Types
Dermatologic,
Melanoma
N/A
Kauffmann, Rondi
VICCMEL0287
Storage and Research Use of Human Biospecimens from Melanoma Patients and Clinical Testing for the Assignment of Therapy
Melanoma
Melanoma
Melanoma
N/A
Johnson, Douglas
NCT01205815
VICCMEL09109
